Cadila Healthcare informs about statement of investor complaints

12 Jan 2018 Evaluate

Cadila Healthcare has informed about Statement of Investor Complaints for the quarter ended on December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

963.85 4.40 (0.46%)
23-Apr-2024 14:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1480.60
Dr. Reddys Lab 5985.75
Cipla 1357.35
Zydus Lifesciences 963.85
Lupin 1585.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.